MENON SANDEEP (Chief R&D Officer) received a stock award from BIOCRYST PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/7/2026ACC: 0000882796-26-000019
Officer· Chief R&D Officer
Since Apr 2026
+646.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
646.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+205.15K
Price / share
—
Trade value
—
% of position
New position
4/6/2026
0.00→205.15K
Total
Net shares
+205.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | A · Award | +205.15K | — | — | New position | 0.00 | 205.15K |
| Total | +205.15K | $0.00 | ||||||
Derivative Transactions1
Emp. Stock Option (Right to Buy)
Direct
Converts to
Common Stock
441.35K shares
Shares
+441.35K
Strike price
9.47
Held after
441.35K
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) Direct | Common Stock441.35K shares | 4/6/2026 | A · Award | +441.35K | 9.47 | — | 441.35K |